PharmaNest to Present Six Digital Pathology Abstracts at the International Liver Congress-EASL 2023,
PharmaNest, a leader in high resolution, single-fiber, quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest Ph-FCS continuous fibrosis biomarker for the quantification of the severity of fibrosis and prognostics of liver related clinical events in NASH....
United States New York Mathieu Petitjean Manuel Romero Gomez Pharmanest Inc International Liver Congress
Source: pharmiweb.com